Why a memory pathway becomes overactive in Alzheimer’s
Mechanisms of pathology and neuronal hyperactivity in a memory circuit in Alzheimer's disease
['FUNDING_R01'] · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · NIH-11120983
This project looks at whether Alzheimer’s-linked amyloid builds up on a specific memory pathway and makes those brain cells overactive, which could worsen memory in people with Alzheimer’s.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (nih funded) |
| Locations | 1 site (CAMBRIDGE, UNITED STATES) |
| Trial ID | NIH-11120983 on ClinicalTrials.gov |
What this research studies
Researchers are studying a memory-related brain circuit centered on the mammillary body using advanced mouse models that carry human Alzheimer’s mutations. They combine single-cell gene profiling, targeted circuit mapping, high-resolution expansion microscopy, and recordings of neuronal activity to see which neurons and axons carry amyloid and become hyperactive. The team is building new tools to trace connections from the hippocampus (subiculum) to a vulnerable group of mammillary body neurons and to test whether these axons show abnormal excitability. The work aims to link microscopic patterns of amyloid to nerve activity changes that could underlie memory loss.
Who could benefit from this research
Good fit: Although this is primarily animal research, the most relevant people would be individuals with early Alzheimer’s disease or those at genetic risk (for example, APOE ε4 carriers) who might join future trials informed by these findings.
Not a fit: People whose memory problems are caused by non‑Alzheimer processes or who are in very late-stage dementia are less likely to receive direct benefit from this project.
Why it matters
Potential benefit: If successful, this work could identify new targets to prevent or reduce harmful brain overactivity and help slow memory decline in people with Alzheimer’s.
How similar studies have performed: Prior mouse studies have linked circuit hyperactivity to memory problems and shown that dampening overactive neurons can improve symptoms in animals, but moving these findings into effective human treatments remains largely untested.
Where this research is happening
CAMBRIDGE, UNITED STATES
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY — CAMBRIDGE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BOYDEN, EDWARD S. — MASSACHUSETTS INSTITUTE OF TECHNOLOGY
- Study coordinator: BOYDEN, EDWARD S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease, Alzheimer's disease model